Pharmacist prescribing within a UK NHS hospital trust: nature and extent of prescribing, and prevalence of errors

Baqir, Wasim; Crehan, Olga; Murray, Richard; Campbell, David; Copeland, Richard

doi:10.1136/ejhpharm-2014-000486

Cited by 44 publications

(43 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A study by Baqir and colleagues [Baqir et al 2014] focused on the nature and extent of prescribing and prevalence of errors by pharmacist NMPs, specifically within a UK NHS hospital. Results from this study demonstrated an error rate of 0.3% of medication orders generated by pharmacist prescribers.…”

Section: Impact Of Nonmedical Prescribingmentioning

confidence: 99%

Nonmedical prescribing: where are we now?

Cope¹,

Abuzour

Tully

2016

Therapeutic Advances in Drug Safety

145

134

View full text Add to dashboard Cite

Nonmedical prescribing has been allowed in the United Kingdom (UK) since 1992. Its development over the past 24 years has been marked by changes in legislation, enabling the progression towards independent prescribing for nurses, pharmacists and a range of allied health professionals. Although the UK has led the way regarding the introduction of nonmedical prescribing, it is now seen in a number of other Western-European and Anglophone countries although the models of application vary widely between countries. The programme of study to become a nonmedical prescriber (NMP) within the UK is rigorous, and involves a combination of taught curricula and practice-based learning. Prescribing is a complex skill that is high risk and error prone, with many influencing factors. Literature reports regarding the impact of nonmedical prescribing are sparse, with the majority of prescribing research tending to focus instead on prescribing by doctors. The impact of nonmedical prescribing however is important to evaluate, and can be carried out from several perspectives. This review takes a brief look back at the history of nonmedical prescribing, and compares this with the international situation. It also describes the processes required to qualify as a NMP in the UK, potential influences on nonmedical prescribing and the impact of nonmedical prescribing on patient opinions and outcomes and the opinions of doctors and other healthcare professionals.

show abstract

Section: Impact Of Nonmedical Prescribingmentioning

confidence: 99%

Nonmedical prescribing: where are we now?

Cope¹,

Abuzour

Tully

2016

Therapeutic Advances in Drug Safety

145

134

View full text Add to dashboard Cite

show abstract

“…Electronic medical notes were then individually reviewed by VC (principal author and non-prescribing clinical pharmacist at foundation level in critical care pharmacy practice10) for further details on the indication of pharmacist prescribing and data related to second pharmacist ‘clinical check’ activity. The indications for pharmacist prescribing were recorded and categorised according to a 2014 survey of critical care pharmacist practice3 and a 2014 study of pharmacist prescribing in general hospital practice 8. The medicine prescriptions were categorised according to the primary indication for prescribing with determination from the medical note entry.…”

Section: Methodsmentioning

confidence: 99%

Pharmacist prescribing in critical care: an evaluation of the introduction of pharmacist prescribing in a single large UK teaching hospital

et al. 2017

View full text Add to dashboard Cite

ObjectivesTo evaluate the introduction of pharmacist independent prescribing activity across three general critical care units within a single large UK teaching hospital. To identify the prescribing demographics including total of all prescriptions, number prescribed by pharmacists, reason for pharmacist prescription, range of medications prescribed, pharmacist prescribing error rate and the extent of pharmacist second ‘clinical check’.MethodsRetrospective evaluation of e-prescribing across all general critical care units of a single large UK teaching hospital. All prescribing data were downloaded over a 1-month period (May to June 2016) with analysis of pharmacist prescribing activity including rate, indication, therapeutic class and error rate.ResultsIn total, 5374 medicines were prescribed in 193 patients during the evaluated period. Prescribing pharmacists were available on the units on 60.4% (58/96) of days, during their working hours and accounted for 576/5374 (10.7%) of medicines prescribed in 65.2% (126/193) of patients. The majority (342/576) of pharmacist prescriptions were for new medicines. Infections, central nervous system, and nutrition/blood were the top three British National Formulary (BNF) therapeutic categories, accounting for 63.4% (349/576) of all pharmacist prescriptions. The critical care pharmacist prescribing error rate was 0.18% (1/550).ConclusionsPharmacist independent prescribers demonstrated a high degree and wide-ranging scope of prescribing activity in general critical care patients. Pharmacists contributed a significant proportion of total prescribing, despite less than full service coverage. Prescribing activity was also safe with a very low error rate recorded.

show abstract

“…15e17 While there are limited data, one study of pharmacist prescribing in hospitals in England reported error prevalence of 0.3% of prescriptions written. 18 The scope of pharmacist prescribing in hospital is developing continually. Hospital pharmacists prescribe in a diverse range of clinical specialities including acute medicine, antimicrobials, cardiology, diabetes, hypertension, mental health, neurology, pain management, oncology, orthopaedics and respiratory.…”

Section: Introductionmentioning

confidence: 99%